Literature DB >> 25943424

Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation.

Majid Ghayour-Mobarhan1, Mohsen Moohebati, Habibollah Esmaily, Mahmoud Ebrahimi, Seyed Mohammad Reza Parizadeh, Ali Reza Heidari-Bakavoli, Mohammad Safarian, Naghmeh Mokhber, Mohsen Nematy, Hamidreza Saber, Maryam Mohammadi, Mohammad Sobhan Sheikh Andalibi, Gordon A Ferns, Mahmoud Reza Azarpazhooh.   

Abstract

OBJECTIVE: The Mashhad stroke and heart atherosclerotic disorder (MASHAD) study is a 10-year cohort study that aims to evaluate the impact of various genetic, environmental, nutritional and psychosocial risk factors on the incidence of cardiovascular events among an urban population in eastern Iran.
METHODS: The MASHAD study comprises a cohort of 9704 individuals aged 35-65 years using a stratified cluster random sampling design. This cohort will be followed up until 2020, with follow-up examinations being undertaken every 3 years. Ten-year cardiovascular disease (CVD) risk estimation was determined using NCEP ATP III criteria.
RESULTS: Overall, 88.4 % of women and 79.2 % of men (P < 0.001) had at least one lipid abnormality. The 10-year risk for CVD of <10, 10-20 and >20 % were observed to be 86.6, 11 and 2.5 %, respectively. Predicted risk of CVD > 10 % using the Framingham algorithm was considerably higher in men compared to women. Overall, 9.5 % [95 % confidence interval (CI) 8.9-10.1 %] of our subjects had prevalent CAD.
CONCLUSION: The prevalence of CVD risk factors within our population is high compared to Western countries, indicating the necessity for interventional risk modifications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25943424     DOI: 10.1007/s00038-015-0679-6

Source DB:  PubMed          Journal:  Int J Public Health        ISSN: 1661-8556            Impact factor:   3.380


  32 in total

1.  Global epidemic of cardiovascular disease predicted.

Authors:  L Husten
Journal:  Lancet       Date:  1998-11-07       Impact factor: 79.321

2.  Experience from a multicentre stroke register: a preliminary report.

Authors:  S Hatano
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

3.  Cardiovascular disease in developing countries.

Authors:  R Beaglehole
Journal:  BMJ       Date:  1993-02-06

4.  Cardiovascular disease in developing countries.

Authors:  M A Najeeb
Journal:  BMJ       Date:  1993-04-03

5.  Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan.

Authors:  N Sarraf-Zadegan; M Boshtam; H Malekafzali; N Bashardoost; F A Sayed-Tabatabaei; M Rafiei; A Khalili; S Mostafavi; M Khami; R Hassanvand
Journal:  Acta Cardiol       Date:  1999-12       Impact factor: 1.718

6.  PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis.

Authors:  H Uthoff; D Staub; T Socrates; A Meyerhans; B Bundi; H P Schmid; B Frauchiger
Journal:  Vasa       Date:  2010-11       Impact factor: 1.961

7.  Prevalence of coronary heart disease risk factors in Costa Rican adolescents.

Authors:  R Monge; O Beita
Journal:  J Adolesc Health       Date:  2000-09       Impact factor: 5.012

8.  Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993.

Authors:  R Beaglehole; A W Stewart; R Jackson; A J Dobson; P McElduff; K D'Este; R F Heller; K D Jamrozik; M S Hobbs; R Parsons; R Broadhurst
Journal:  Am J Epidemiol       Date:  1997-04-15       Impact factor: 4.897

9.  Status of cardiovascular health in a transition European country: findings from a population-based cross-sectional study.

Authors:  Slavenka Janković; Dragana Stojisavljević; Janko Janković; Miloš Erić; Jelena Marinković
Journal:  Int J Public Health       Date:  2014-08-01       Impact factor: 3.380

10.  Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran.

Authors:  Hadi Harati; Farzad Hadaegh; Navid Saadat; Fereidoun Azizi
Journal:  BMC Public Health       Date:  2009-06-16       Impact factor: 3.295

View more
  27 in total

1.  Prevalence of combined and noncombined dyslipidemia in an Iranian population.

Authors:  Susan Darroudi; Maryam Saberi-Karimian; Maryam Tayefi; Soheil Arekhi; Ali Motamedzadeh Torghabeh; Seyed Mohammad Reza Seyedzadeh Sani; Mohsen Moohebati; Alireza Heidari-Bakavoli; Mahmoud Ebrahimi; Mahmoud Reza Azarpajouh; Mohammad Safarian; Gordon A Ferns; Habibollah Esmaeili; Mohammad Reza Parizadeh; Naghme Mokhber; Adeleh Mahdizadeh; Ali Asghar Mahmoudi; Amir Hossein Sahebkar; Majid Ghayour-Mobarhan
Journal:  J Clin Lab Anal       Date:  2018-06-21       Impact factor: 2.352

2.  Association of hematocrit with blood pressure and hypertension.

Authors:  Marzieh Emamian; Seyed Mahdi Hasanian; Maryam Tayefi; Moniba Bijari; Faeze Movahedian Far; Mojtaba Shafiee; Amir Avan; Alireza Heidari-Bakavoli; Mohsen Moohebati; Mahmoud Ebrahimi; Sousan Darroudi; Parvin Zamani; Mahmoud Reza Azarpazhooh; Mohsen Nematy; Mohammad Safarian; Gordon A Ferns; Habibollah Esmaeili; Mohammad Reza Parizadeh; Majid Ghayour-Mobarhan
Journal:  J Clin Lab Anal       Date:  2017-01-20       Impact factor: 2.352

3.  Decreased Threshold of Fasting Serum Glucose for Cardiovascular Events: MASHAD Cohort Study.

Authors:  Fatemeh Sadabadi; Aida Gholoobi; Alireza Heidari-Bakavol; Mohsen Mouhebati; Ali Javandoost; Zahra Asadi; Maryam Saberi-Karimian; Susan Darroudi; Mohammad Sadegh Khorrami Mohebbseraj; Farzad Rahmani; Najmeh Malekzadeh Gonabadi; Fatemehalsadat Jafari Sheshtamad; Sara Samadi; Afsane Bahrami; Gordon Ferns; Majid Ghayour-Mobarhan; Habibollah Esmaeili
Journal:  Rep Biochem Mol Biol       Date:  2020-04

4.  A Genetic Variant in Proline and Serine Rich Coiled-Coil 1 Gene Is Associated with the Risk of Cardiovascular Disease.

Authors:  Mohammad Sadegh Khorrami; Fatemeh Sadabadi; Alireza Pasdar; Hamide Safarian-Bana; Forouzan Amerizadeh; Habibollah Esmaeily; Mohsen Moohebati; Alireza Heidari-Bakavoli; Gordon Ferns; Majid Ghayour-Mobarhan; Amir Avan
Journal:  Rep Biochem Mol Biol       Date:  2022-01

5.  Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.

Authors:  S R Mirhafez; M Ebrahimi; M Saberi Karimian; A Avan; M Tayefi; A Heidari-Bakavoli; M R Parizadeh; M Moohebati; M R Azarpazhooh; H Esmaily; M Nematy; M Safarian; G A Ferns; M Ghayour-Mobarhan
Journal:  Eur J Clin Nutr       Date:  2016-07-27       Impact factor: 4.016

6.  Serum hs-CRP varies with dietary cholesterol, but not dietary fatty acid intake in individuals free of any history of cardiovascular disease.

Authors:  M Mazidi; A Heidari-Bakavoli; S S Khayyatzadeh; M R Azarpazhooh; M Nematy; M Safarian; H Esmaeili; S M R Parizadeh; M Ghayour-Mobarhan; A P Kengne; G A Ferns
Journal:  Eur J Clin Nutr       Date:  2016-09-28       Impact factor: 4.016

7.  Changes in stroke mortality trends and premature mortality due to stroke in Serbia, 1992-2013.

Authors:  Zana Dolicanin; Dragan Bogdanovic; Konstansa Lazarevic
Journal:  Int J Public Health       Date:  2015-11-05       Impact factor: 3.380

8.  Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations.

Authors:  Sara Samadi; Samaneh Abolbashari; Zahra Meshkat; Amir Hooshang Mohammadpour; Theodoros Kelesidis; Aida Gholoobi; Mehrane Mehramiz; Mahla Tabadkani; Fatemeh Sadabadi; Razieh Dalirfardouei; Gordon A Ferns; Majid Ghayour-Mobarhan; Amir Avan
Journal:  Biofactors       Date:  2019-01-29       Impact factor: 6.113

9.  High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort.

Authors:  Sara Samadi; Mehrane Mehramiz; Theodoros Kelesidis; Majid Ghayour Mobarhan; Amir Hosein Sahebkar; Habibollah Esmaily; Mohsen Moohebati; Zahra Farjami; Gordon A Ferns; Amir Hooshang Mohammadpour; Amir Avan
Journal:  J Cell Physiol       Date:  2019-02-19       Impact factor: 6.384

10.  Adult Celiac Disease: Patients Are Shorter Compared with Their Peers in the General Population.

Authors:  Abbas Esmaeilzadeh; Azita Ganji; Ladan Goshayeshi; Kamran Ghafarzadegan; Mehdi Afzal Aghayee; Homan Mosanen Mozafari; Hassan Saadatniya; Abdolrasol Hayatbakhs; Vahid Ghavami Ghanbarabadi
Journal:  Middle East J Dig Dis       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.